The Glenrose Rehabilitation Hospital is located in Edmonton, Alberta, Canada. The Glenrose opened in 1964, and offers services to children and adults on an inpatient, outpatient and outreach basis.

There are 244 beds in Glenrose Rehabilitation Hospital.

During the past decade, Glenrose Rehabilitation Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Glenrose Rehabilitation Hospital" #1 sponsor was "University of Alberta" with 3 trials, followed by "GlaxoSmithKline" with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "OPKO Health, Inc." with 2 trials sponsored and "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glenrose Rehabilitation Hospital" #1 collaborator was "Alberta Health services" with 2 trials as a collaborator, "Alberta Children's Hospital" with 1 trials as a collaborator, "Austin Hospital, Melbourne Australia" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Centre for Aging and Brain Health Innovation" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Glenrose Rehabilitation Hospital" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Cerebral Palsy" (2 trials), "Epilepsy" (2 trials) and "Huntington Disease" (2 trials). Many other conditions were trialed in "Glenrose Rehabilitation Hospital" in a lesser frequency.

Most popular intervention types in "Glenrose Rehabilitation Hospital" are "Drug" (11 trials), "Device" (6 trials), "Other" (6 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ACR16 10 mg" (1 trials), "ACR16 22.5 mg" (1 trials), "ACR16 45 mg" (1 trials) and "AboBoNT-A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glenrose Rehabilitation Hospital" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Glenrose Rehabilitation Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Glenrose Rehabilitation Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Glenrose Rehabilitation Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".